NASDAQ:CHRS | EBITDA Margin | Coherus Oncology, Inc.

Complete source-backed ebitda margin history.

Available history
2012-12-31 to 2025-12-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2025-12-31-357.55%
2025-09-30-380.55%
2025-06-30-440.67%
2025-03-31-592.64%
2024-12-31-585.59%
2024-09-30-767.61%
2024-06-30-380.01%
2024-03-31-2911.05%
2023-12-31-74.52%
2023-09-30-41.85%
2023-06-30-57.47%
2023-03-31-206.08%
2022-12-31-111.34%
2022-09-30-175.13%
2022-06-30-71.67%
2015-06-30-851.95%
2015-03-31-628.50%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-426.43%
2024-12-31-750.51%
2023-12-31-77.75%
2022-12-31-120.01%
2021-12-31-79.73%
2014-12-31-205.77%
2013-12-31-1293.68%
2012-12-31-2016.69%